USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/14997
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGhilețchii, Alexandru,-
dc.contributor.authorRotaru, Tudor-
dc.date.accessioned2021-01-09T09:12:58Z-
dc.date.available2021-01-09T09:12:58Z-
dc.date.issued2020-
dc.identifier.citationGHILEȚCHII, Alexandru, ROTARU, Tudor. New approaches in the treatment of high-grade intraepithelial lesions of the cervix = Noi abordări în tratamentul leziunilor intraepiteliale de grad sporit ale colului uterin. In: Congresul consacrat aniversării a 75-a de la fondarea USMF „Nicolae Testemițanu”, 21-23 octombrie 2020: Abstract book. Chișinău: [s. n.], 2020, p. 596.en_US
dc.identifier.urihttps://stiinta.usmf.md/sites/default/files/inline-files/Abstract%20Book.%20CULEGERE%20DE%20REZUMATE%20.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/14997-
dc.description.abstractBackground. In 2018, according to the latest GLOBOKAN data, 527,600 new cases of cervical cancer patients and 265,700 deaths were diagnosed worldwide. The most important risk factor is HPV infection. Treatment of HSIL lesions of the cervix associated with HPV may delay or prevent progression to cervical cancer. Objective of the study. The aim of this study is to evaluate surgical, antiviral and immunomodulatory treatment in patients with HSIL of the cervix. Material and Methods. This is a prospective study of 26 patients with high-grade intraepithelial lesions of cervical malignancy (CIN II, CIN III, CIS) treated surgically, antivirally and immunomodulatory during the years 2017-2020 in IMSP Oncological Institute of the Republic of Moldova. Results. Case reports of patients which have been analysed ranged from 23 to 48 years old. The average age of the examined patients was 33 years. Patients with HSIL were treated surgically with LLETZ (89%) and total hysterectomy (11%). The postoperative histological result was CIN II-33%, CIN III-56% and CIS-11%. Antiviral therapy was administered to 28% of patients, antiviral and immunomodulatory therapy was administered to 88%, and 12% of patients did not receive any treatment. All patients were monitored by liquid-based cytology + HPV genotyping at 6 months, 88.46% were determined NILM with negative HPV, 11.54%- were determined LSIL + HPV positive insignificant load. Conclusion. The treatment of high-grade neoplasms of the cervix is combined surgically, antiviral and immunomodulatory. At follow-up the cytology was NILM and HPV negative in 88.46% of patients, thus decreasing the risk of recurrence of the disease and a subsequent transformation to cervical carcinoma. Introducere. Conform datelor GLOBOKAN din 2018, pe glob au fost diagnosticate 527600 cazuri noi și 265700 decese provocate de cancerul de col uterin. Factorul de risc major este infecţia cu HPV. Tratamentul leziunilor HSIL de col uterin, asociate cu HPV, pot întârzia sau preveni progresia spre cancer cervical. Scopul lucrării. Evaluarea tratamentului chirurgical, antiviral și imunomodulator la pacientele cu HSIL colului uterin. Material și Metode. Este un studiu prospectiv a 26 paciente cu HSIL ale colului uterin (CIN II, CIN III, Ca is), tratate chirurgical, antiviral și imunomodulator, pe parcursul anilor 2017-2020 în IMSP Institutul Oncologic din Republica Moldova. Rezultate. Vârsta pacientelor a fost de la 23 la 48 ani, vârsta medie- 33 ani. Pacientele cu HSIL au fost tratate chirurgical prin LEETZ (89%) şi prin histerectomie totală (11%). Rezultatele histologice postoperatorii au determinat CIN II- 33%, CIN III- 56% și CIS- 11%. La 28% dintre paciente s-a administrat tratament antiviral şi la 88%- tratament antiviral și imunomodulator, la 12% paciente tratament antiviral nu a fost administrat. Toate pacientele au fost monitorizate cu colectarea citologiei în mediul lichid+ HPV genotipare la 6 luni. Rezultatele au demonstrat că la 88,46% s-a determinat NILM cu HPV negativ, la 11,54% s-a determinat LSIL+ HPV pozitiv încărcătura sumară neînsemnată. Concluzii. Tratamentul neoplaziilor de grad înalt al colului uterin este combinat chirurgical, antiviral şi imunomodulator. La follow-up citologia a fost NILM şi HPV negativ prezentă la 88,46% dintre paciente, astfel scade riscul de recidivă a bolii şi o ulterioară transformare spre carcinomul cervical.en_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldovaen_US
dc.subjectcarcinoma in situen_US
dc.subjectCIN IIen_US
dc.subjectCIN IIIen_US
dc.subjectHPVen_US
dc.subjectLLETZen_US
dc.titleNew approaches in the treatment of high-grade intraepithelial lesions of the cervixen_US
dc.title.alternativeNoi abordări în tratamentul leziunilor intraepiteliale de grad sporit ale colului uterinen_US
dc.typeOtheren_US
Appears in Collections:Congresul consacrat aniversării a 75-a de la fondarea USMF „Nicolae Testemițanu”, 21-23 octombrie 2020: Abstract book

Files in This Item:
File Description SizeFormat 
596_ABSTRACT_BOOK_Culegere_de_rezumateABSTRACT_BOOK_Culegere_de_rezumate.pdf170.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback